.jpg)
@AuManufacturing Conversations
@AuManufacturing Conversations with Brent Balinski is a regular interview program, bringing you discussions with the folks who are contributing to a critical part of the economy -- one that leads private sector R&D investment, employs well over a million Australians, and is just plain important to have around.
We hope to capture something of the variety of manufacturing, its place in the nation, its changing nature, and some of the personalities within it.
From the boutique to the billion dollar, if it's manufacturing and it's Australian, then it likely matters to us. This podcast is an extension of the @AuManufacturing news and analysis website and the community around it, and complements what's written online at www.aumanufacturing.com.au.
Interested in advertising? Get in touch via editor@aumanufacturing.com.au
@AuManufacturing Conversations
Episode 97 -- Dr Maryam Parviz from SDIP Innovations
In this episode of @AuManufacturing Conversations, Dr Maryam Parviz from bone filler business SDIP Innovations tells us about why better bone implants are needed, the company's road to commercialisation, why the company decided in-house production was the only way after considering contract manufacture, and more.
This episode is sponsored by ECI Software Solutions.
Episode guide
0:26 – What SDIP does – next-generation bioresobable bone implants – and Parviz’s professional background.
2:25 – Development of the implants by the company’s co-founder as an answer to repeat surgeries.
3:30 – The scholarship from NSW Health in partnership with QB3 incubator and the UCSF Rosenman incubator.
4:32 – What Jazbi is and does.
5:40 – 60 per cent of surgeons use bone from another part of the patient’s body, or from cadavers.
7:20 – Their product versus ceramics, which Parvis says are brittle rather than shapeable. Bone fillers created in granule, wedge and rod shape plus fillers (with rod-shaped cartridges) used in a delivery device.
9:26 – What it’s made of and how it’s made.
10:55 – The path to clinical acceptance. Hopefully in a patient next year.
12:40 – The business model.
15:01 – What lure might’ve been attached to staying in the Bay Area and not returning to Sydney to establish the business and its products.
19:07 – Establishing the factory in Hornsby.
22:30 – Manufacturing process development while in the Bay Area and the value of this.
23:50 – Why the fundraising environment for medical device companies in Australia isn’t as mature as it could be, and what this means for new companies.
28:10 – The art of innovation in manufacturing and at SDIP.
30:20 – First sales will be in the US market.
31:15 – The skillsets involved, talent attraction at SDIP, and the challenging nature of this.
